Company Statement:

Kyowa Hakko is a $3 billion, global manufacturer of Health Ingredients for use in the Dietary Supplements, Food, Cosmetic and Pharmaceutical industries. The product portfolioincludes Amino acids, and other related materials. Kyowa Hakko is guided by its corporate mission to improve the health and well-being of people worldwide. Headquartered in Tokyo, Japan, the company operates in North America as Kyowa Hakko U.S.A., Inc., from its main offices in New York and California. Internationally, Kyowa Hakko operates in more than 80 countries through over 50 corporate facilities, subsidiaries and affiliates. Kyowa Hakko has extensive manufacturing and R&D facilities in both Japan and in the US. A pioneer in the development and application of fermentation technology, Kyowa Hakko has maintained a constant commitment to research, developing innovative products and quality management.

Dietary supplements, conventional foods, functional foods, cosmetic, industrial and pharmaceutical industries. Over 50 amino acids and related compounds, including D- Amino Acids and branch-chain amino acids, as well as nucleic acids, bio-products and fine chemicals – L-Arginine, L-Glutamine, L-Leucine, L-Isoleucine, L-Valine and L-Citruline; natural and non-animal origin L-Cysteines, including n-acetyl cysteine.

Kyowa Hakko was the first company in the world to successfully produce and commercialize amino acids, using fermentation methods. ‘Hakko’, in Japanese means fermentation, reflecting its key technology. Over the years, the company has introduced a wide range of fermentation-based amino acids. The company has invested more than $230 million in Research and Development. It employs a staff of over 1,400 researchers and it holds nearly 2,500 patents. The company is US FDA inspected manufacturer, and the vast majority of the products are Kosher with the “Circle K” approval.

Complete product information is available by contacting inquiry@kyowa-usa.com or 212.319.5353.